Omeros (OMER) Q2 FY26 earnings call

Omeros reported a strong first full quarter for YARTEMLEA, exceeding internal forecasts and achieving positive operational cash flow. The company also significantly strengthened its capital structure through share and note repurchases. While European regulatory approval for YARTEMLEA faces a setback, the company remains focused on expanding its MASP-2 platform and advancing a deep pipeline of other programs.